Free Trial

Establishment Labs Holdings Inc. (NASDAQ:ESTA) Holdings Raised by Black Swift Group LLC

Establishment Labs logo with Medical background
Remove Ads

Black Swift Group LLC grew its position in Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 98.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 14,300 shares of the company's stock after purchasing an additional 7,100 shares during the period. Black Swift Group LLC owned approximately 0.05% of Establishment Labs worth $659,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Raymond James Financial Inc. acquired a new position in shares of Establishment Labs during the fourth quarter worth approximately $5,494,000. Handelsbanken Fonder AB boosted its position in Establishment Labs by 32.3% during the 4th quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company's stock worth $378,000 after acquiring an additional 2,000 shares during the period. R Squared Ltd bought a new position in shares of Establishment Labs in the fourth quarter worth $36,000. Assenagon Asset Management S.A. acquired a new position in shares of Establishment Labs during the fourth quarter valued at $12,898,000. Finally, SkyView Investment Advisors LLC raised its stake in shares of Establishment Labs by 30.5% during the third quarter. SkyView Investment Advisors LLC now owns 12,000 shares of the company's stock valued at $519,000 after purchasing an additional 2,805 shares in the last quarter. Institutional investors own 72.91% of the company's stock.

Analyst Ratings Changes

Separately, Stephens reissued an "overweight" rating and set a $52.00 target price on shares of Establishment Labs in a research note on Thursday. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $57.40.

Remove Ads

Read Our Latest Stock Report on ESTA

Establishment Labs Price Performance

Shares of Establishment Labs stock traded down $5.01 during trading on Monday, hitting $36.69. The stock had a trading volume of 835,990 shares, compared to its average volume of 416,988. The business has a fifty day moving average of $37.37 and a two-hundred day moving average of $41.34. The firm has a market cap of $1.06 billion, a P/E ratio of -14.22 and a beta of 0.95. Establishment Labs Holdings Inc. has a fifty-two week low of $28.16 and a fifty-two week high of $60.12. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The company reported ($0.98) earnings per share for the quarter, missing the consensus estimate of ($0.64) by ($0.34). Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. The business had revenue of $44.51 million for the quarter, compared to the consensus estimate of $44.45 million. On average, sell-side analysts expect that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current fiscal year.

Establishment Labs Company Profile

(Free Report)

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.

Recommended Stories

Institutional Ownership by Quarter for Establishment Labs (NASDAQ:ESTA)

Should You Invest $1,000 in Establishment Labs Right Now?

Before you consider Establishment Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Establishment Labs wasn't on the list.

While Establishment Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last

NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last

NVIDIA is falling closer to the $100 mark—could it drop even further? Analysts predict up to 50% upside; is this a buying opportunity or a warning sign?

Related Videos

Is There Still Money in AI? How to Invest in the Next Big Wave
3 AI Stocks to Watch After NVIDIA’s Dip
5 Stocks to BUY NOW in March 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads